T ype 1 diabetes (T1D)
3 is a polygenic disease caused by the loss of insulin-producing ␤ cells, as a consequence of an autoimmune process mediated by the patient's own immune system (1) . Currently, the NOD mouse is one of the best animal models to study this disease, because it spontaneously develops a form of autoimmune diabetes that resembles human T1D (2, 3) . Studies using this animal model have shown that ␤ cell damage is mainly caused by T lymphocytes (4) . However, other cells of the immune system also play a relevant role in the development of the disease. In this regard, it is believed that B lymphocytes may act both as APCs for autoreactive T lymphocytes and/or as producers of autoantibodies against several ␤ cell autoantigens (5, 6) .
The autoimmune response of ␤ cell-reactive T and B lymphocytes in T1D patients and in NOD mice is directed to a wide range of autoantigens (i.e., glutamic acid decarboxylase insulin, islet cell autoantigen 69, S100␤, carboxypeptidase H, heat shock protein 60, IA-2, glial fibrillary acidic protein peripherin, and/or islet-specific glucose-6-phosphatase catalytic subunit-related protein). Most of these autoantigens are found not only in pancreatic ␤ cells, but also in cells from the nervous system (7) . In fact, islet ␤ cells and neurons share several phenotypical similarities, thus suggesting the same ectodermic origin (8, 9) . Moreover, the hypothesis of a sole autoimmune response against islet ␤ cells in T1D is controversial because several studies have demonstrated that the pancreatic nervous system is also affected by the autoimmune response during the development of T1D (10 -12) . In this regard, it has been hypothesized that this response to the pancreatic nervous system may precede the attack on pancreatic ␤ cells.
During the development of T1D, B lymphocytes migrate to the pancreatic islets but their exact role remains poorly understood. At present, very few studies have analyzed the nature of the B lymphocyte population that infiltrates the islets. Although the results obtained from these studies are often divergent (13) (14) (15) 46) , they all suggest that islet-infiltrating B lymphocytes play a crucial role in T1D.
To elucidate the antigenic repertoire of islet-infiltrating B lymphocytes, we generated hybridoma cell lines of infiltrating B lymphocytes from different mouse strains developing insulitis (16) . We found that many hybridomas (56%) produced mAbs restricted to the peripheral nervous system (PNS) elements. Ig class analyses indicated that these islet-derived hybridomas came from B lymphocytes that had undergone Ig class switch recombination. Therefore, islet-associated B lymphocytes are involved in active, Thdriven immune responses against local antigenic targets.
The aim of the present study was to identify the autoantigen recognized by these mAbs. Interestingly, we discovered that peripherin is the autoantigen recognized by all mAbs [21/21] . Despite being an intermediate filament protein predominantly found in PNS, it has been demonstrated that peripherin is also produced by ␤ cells. Three peripherin isoforms have been described: Per58, Per61, and Per56. In our study, we have observed that all mAbs recognize Per58 and Per61 isoforms, whereas only one [1/21] also recognizes Per56 isoform. Because the only difference between Per58 and Per61, compared with Per56, is the last 21 C-terminal amino acids, our results indicate that the epitope recognized by most mAbs is found at the C-terminal end of both Per58 and Per61 isoforms. In conclusion, peripherin may be a crucial autoantigen during the development of T1D.
Materials and Methods

Mice
Breeding pairs of NOD mice were purchased from The Jackson Laboratory and maintained by brother-sister mating at our animal facility under specific pathogen-free conditions. Institutional guidelines for animal welfare, according to European Laws and European Community Directives, were followed.
Cell lines
Previously generated islet-infiltrating B cell-derived hybridomas showing neuronal staining pattern over tissue cryosections (16) were expanded and culture supernatants collected for further studies. The 21 hybridomas come from 10 independent procedures conducted using islet-infiltrating mononuclear cells from pools of pancreatic islets isolated from two to five mice. Two of these hybridoma cell lines derived from islet-infiltrating B lymphocytes of NOD mice, three from 8.3-NOD, seven from (NOD ϫ NOR)F 1 , and nine from 8.3-(NOD ϫ NOR)F 1 mice (Table I) . Neuroblastoma cell line N1E-115, insulinoma NIT-1, and control fibroblast SV-T2 were obtained from the American Type Culture Collection. The human adrenal carcinoma cell line, SW13 vim(Ϫ), which lacks cytoplasmic intermediate filaments, was provided by Dr. J. Robertson (Centre for Research in Neurodegenerative Diseases, Toronto, Canada) (17) .
Immunofluorescence staining
Cells were cultured on slides overnight at 37°C in 5% CO 2 to allow them to attach to the glass. Slides were then rinsed in PBS and later cells were fixed in 4% formaldehyde and permeabilized in 0.1% saponin. After washing with PBS, cells were incubated with hybridoma supernatants overnight at 4°C, washed with PBS, and labeled with Alexa 488-conjugated goat anti-mouse IgG2b (Molecular Probes). The isotype control that was used was irrelevant IgG2b mouse monoclonal.
Cryosections (5 m) from pancreases of NOD.RAG-2 Ϫ/Ϫ mice were air dried for 30 min, incubated at 4°C overnight with 30 l of each hybridoma supernatant, washed, and then incubated with the secondary Ab (goat antimouse IgMϩGϩA-FITC, from Southern Biotechnology Associates) at 4°C for 45 min. Double staining was achieved with two more incubation steps with a guinea pig anti-pig insulin (Sigma-Aldrich) and subsequently with a goat anti-guinea pig IgG-TRITC (ICN Biomedicals).
Protein extraction and Western blot analysis
Cultured cells or freshly isolated pancreatic islets from 4-wk-old NOD mice (18) were washed twice in PBS before protein extraction with ProteoExtract Subcellular Proteome Extraction kit (Calbiochem). We obtained four protein fractions from cytosol, membrane/organelle, nucleus and cytoskeleton compartments (i.e., F1, F2, F3, and F4, respectively). Then, we loaded 10 g of protein/well and electrophoresed in 4 -12% SDS gels (Invitrogen Life Technologies), and subsequently electrotransferred to nitrocellulose membranes (Amersham Biosciences). Right protein transference was always assessed by Ponceau S staining (Sigma-Aldrich) before membrane blocking for 2 h using 2.5% fat-free milk powder and 0.1% Tween 20 (Sigma-Aldrich) in PBS. After several washes with PBS, membranes were incubated overnight at 4°C with hybridoma supernatants, diluted 1/10 in PBS containing 1% milk powder, and 0.1% Tween 20. Next, the membranes were washed in PBS and incubated with peroxidase-conjugated goat anti-mouse Ig (BD Pharmingen) diluted to 1/1000 for 1 h. After several washes, the membranes were developed with the chemiluminescent substrate (SuperSignal; Pierce) and exposed to autoradiography film (Hyperfilm ECL; Amersham Biosciences). For positive controls, we used goat anti-peripherin (C-19; Santa Cruz Biotechnology; generated against a peptide mapping at the C-terminal region of peripherin); rabbit anti-peripherin (Covance; raised against the entire protein) detected with peroxidase-conjugated donkey anti-goat IgG (Jackson ImmunoResearch Laboratories) or peroxidase-conjugated donkey anti-rabbit IgG (Pierce).
Two-dimensional (2-D) electrophoresis
For 2-D protein separation, 50 g of protein extract were acetone precipitated and resuspended in 7 M urea 2 M tio-urea 4% CHAPS 65 mM DTT. Then, samples were loaded into immobilized pH gradient (IPG) strips (BioRad) during rehydration, according to the manufacturer's instructions. Isoelectric focusing was performed into a Protean IEF Cell (Bio-Rad), according to IPG pH range. Before running the second dimension in 4 -12% SDS gels (ZOOM Gel; Invitrogen Life Technologies), IPG strips were equilibrated in SDS-containing buffer. Finally, the obtained 2-D SDS gels were immunoblotted as previously described, or alternatively silver stained (SilverQuest; Invitrogen Life Technologies) for spot identification by mass spectrometry.
In-gel digestion and mass spectrometry
Spots from silver-stained 2D gels were cut and digested overnight with 100 -150 ng of trypsin (Promega) at 37°C using a Montage In-Gel Digest_ZP (Millipore) and following the standard manufacturer's protocol.
Peptides were dried and resuspended in water 0.1% trifluoroacetic acid. A half microliter of them were mixed with an equal amount of a-Cyano-4-hydroxycinnamic acid (3 mg/ml) and analyzed with a MALDI-ToF Voyager DE Pro mass spectrometer (Applied Biosystems) operated in delayed extraction reflector mode at 20 kV as accelerating voltage, 90 ns of pulse delay time, 75% of a grid voltage, and a guide wire voltage of 0.005%. Spectra were accumulated for 100 laser shots and analyzed using MSFit software of Protein Prospector version v 3.2.1 using Swissprot as database search.
Transient transfections
The mouse peripherin isoform cDNAs, Per56, Per58, and Per61, cloned into the mammalian expression vector pRcCMV, were obtained from Dr. J. Robertson (17) . SW13 vim(Ϫ) cells were transiently transfected using Lipofectamine 2000 (Invitrogen Life Technologies). Forty-eight hours after transfection, cells were harvested and protein extraction and Western blot analysis were performed as previously described.
Results
All mAbs targeting PNS elements recognize a 58-kDa protein produced in neuroblastoma and insulinoma cell lines
For this study, we selected 21 islet-derived Ab-secreting hybridomas originated from islet-infiltrating B lymphocytes with specificity for pancreatic nervous system elements (referred to in Ref. 16 as the G neuronal staining pattern (Table I and Fig. 1A ). Please notice that in the previous manuscript, 25 Ab-secreting hybridomas with this same staining pattern were analyzed. In the present manuscript, 4 of them are not described. This is due to the fact that one of them was unstable and lost its capacity to produce Abs, whereas the remaining 3 share the same Ig V region sequence with other hybridomas already analyzed in this study). We chose mAb 228E1 as the representative of this group to perform the first studies. Because the nervous system represents a very small portion of the pancreatic tissue, we tested the mouse neuroblastoma N1E-115 cell line as a putative Ag source. Immunofluorescence staining on N1E-115 cells indicated that the Ag recognized by the 228E1 mAb was present in this neuroblastoma cell line. The stain was a reticular pattern characteristic of an intermediate filament network (Fig. 1B) . The same staining pattern was observed when testing neuroblastoma cell lines from rats or humans (data not shown).
Following the identification of N1E-115 cells as Ag source, we determined the molecular characteristics of the autoantigen. We split protein extraction of N1E-115 cells using a protocol based on sequential extraction buffers with different solubilizing properties. This allowed us to divide the cellular proteome into cytosol, membrane/organelle, nuclear, and cytoskeleton fractions (hereinafter F1, F2, F3, and F4, respectively). After SDS-PAGE and Western blot analysis using 228E1 mAb, we detected a 58-kDa protein of the cytoskeleton fraction ( Fig. 2A) . Next, we conducted the same studies on NIT-1 insulinoma and pancreatic islet extracts to determine whether 228E1 mAb also recognized a protein present on islet ␤ cells. In both cases, the same 58-kDa protein was detected (Fig. 2B) .
We also performed Western blot analysis using the cytoskeleton protein fraction from N1E-115 cells to determine whether the other mAbs with specificity for PNS recognized the same specificity. As shown in Fig. 3 , we observed a band of 58 kDa in all 20 cases, strongly suggesting that all mAbs targeting nervous system elements recognized the same autoantigen. A second band was detected in the immunoblotting in three cases, indicating that mAbs may react with different isoforms of the same protein and/or with other Ags found in the N1E-115 extract. Most anti-peripherin mAbs target an epitope mapping at the C-terminal region of Per58 and Per61 peripherin isoforms. A, Schematic representation of the three peripherin isoforms, generated by alternative splicing of the same mRNA. Per58 is the major constitutive form; Per61 results from the insertion of 32 aa in the rod part, corresponding to the I4 intron of the protein; Per56 results from the use of a cryptic acceptor site at the beginning of the last exon, leading to a deletion and a change in the reading frame, thus replacing the C-terminal 21 aa with a different 8-aa sequence. B, SW13 vim(Ϫ) cells were transiently transfected with cDNA encoding each peripherin isoform. Peripherin production was assessed by Western blot analysis on cytoskeleton protein fractions (fraction F4) of transfected SW13 vim(Ϫ) cells using a polyclonal anti-peripherin Ab (anti-peripherin Ab generated against the full-length protein, which recognize all three peripherin isoforms). Production of all three isoforms was detected in transfected SW13 vim(Ϫ) cells. C, All 21 anti-peripherin mAbs targeted Per58 and Per61, whereas only one [1/21] also reacted with the Per56 peripherin isoform, thus indicating that most mAbs bind to an epitope that maps at the C-terminal region of the Per58 and Per61 isoforms. We show the Western blot analysis on cytoskeleton protein fractions of transfected SW13 vim(Ϫ) cells using the 228E1 mAb, which reacts with Per58 and Per61, but not with Per56 peripherin isoforms. As a positive control, we used a goat anti-peripherin Ab (C-19) raised against a peptide mapping at the C-terminal region of peripherin. a Twenty-four peptides derived from peripherin were identified by mass spectrometry analysis. The peptide sequence and peptide location on the protein sequence are shown. Note that some of these peptides result from posttranslational modifications. There are 26 peptides on the list, but two pairs of them are alternative possibilities corresponding to the same submitted m/z. Together, the 24 peptides covered 220 aa of the protein, which is equivalent to 46% of the whole protein sequence.
Peripherin is the 58-kDa candidate autoantigen
To further characterize the 58-kDa autoantigen, we performed 2-D gel electrophoresis (using the cytoskeleton protein fraction from N1E-115), followed by Western blot analysis with the 228E1 mAb. The results indicated that the 58-kDa autoantigen had an isoelectric point of 5.6 with a microheterogenicity probably caused by posttranslational modifications (Fig. 4, A and B) . Similar results were obtained when 2-D was conducted with the protein extract of the NIT-1 insulinoma cell line (data not shown). To determine the molecular nature of 58-kDa protein, we carefully cut away the spot detected by immunoblotting from a silver-stained 2-D electrophoresis gel and then we subjected the sample to in-gel digestion with trypsin and mass spectrometry analysis. Mass spectrometry analysis assigned 24 different peptides (64% of the peptides analyzed) to the mouse peripherin protein (accession no. P15331, SwissProt), resulting in a molecular weight search score of 1.2 ϫ 10 11 (Fig. 4C) . Combined, these peptides covered 46% of the whole protein sequence (Table II) , thus indicating that peripherin was the protein targeted by the 228E1 mAb.
Most anti-PNS mAbs recognize a dominant epitope mapping at the C-terminal region of the Per58 and Per61 peripherin isoforms
After discovering that peripherin was the Ag targeted by the 228E1 mAb, we analyzed whether the remaining 20 mAbs with specificity for PNS also recognized peripherin. We analyzed the reactivity of these mAbs on SW13 vim(Ϫ) cells, which lack the endogenous intermediate filament network, transfected with mouse peripherin cDNA. Three peripherin protein isoforms (19) produced by alternative mRNA splicing from a unique mouse peripherin gene have been described. Per58 isoform is encoded by all nine exons of the peripherin gene, whereas Per61 includes intron 4 in the central rod. A replacement of the C-terminal 21 aa with a unique 8 aa sequence (Fig. 5A) differentiates Per56 from Per58 and Per61 isoforms. In vivo production levels of Per58 are very high, whereas those of Per61 and Per56 are very low (20) . Therefore, to investigate which peripherin isoform was targeted by our mAbs, three mammalian expression plasmids encoding the peripherin isoforms Per58, Per56, or Per61 were transfected into SW13 vim(Ϫ) cells, and the reactivity of mAbs was analyzed (Fig. 5, B and C) . Interestingly, 20 of the 21 mAbs reacted with Per58 and Per61 peripherin isoforms, but not with Per56. This same pattern was shown by a polyclonal Ab generated against the C-terminal peptide of the Per58 isoform (Fig. 5C) . Thus, the results strongly suggest that the B lymphocyte response against peripherin is directed against an immune dominant epitope mapping at the C-terminal end of the Per58 and Per61 isoforms.
Discussion
In a previous study, we generated hybridoma cell lines from different mouse strains developing insulitis (NOD, 8.3-NOD, (NOD ϫ NOR)F 1 , and 8.3-(NOD ϫ NOR)F 1 mice; Ref. 16) to analyze the antigenic repertoire of islet-infiltrating B lymphocytes to different degrees of susceptibility to T1D. Surprisingly, the characterization of the tissue specificity of the Abs secreted by these cells revealed that a predominant fraction of these hybridomas produced Abs specific for PNS (ϳ16% Ab-secreting hybridomas obtained from islet-infiltrating B lymphocytes of NOD and 8.3-NOD mice, and ϳ45% in (NOD ϫ NOR)F 1 and 8.3-(NOD ϫ NOR)F 1 mice displayed the same the G neuronal staining pattern). This finding indicated a predominant active B lymphocyte response in islets against PNS elements, especially in those mice with more resistance to the disease development. In this study, we demonstrate that all these mAbs selectively target peripherin, thus suggesting that a relevant population of islet-infiltrating B lymphocytes directs their immune response against this neuroendocrine autoantigen.
Peripherin is a cytoskeleton class III intermediate filament with a neuroendocrine tissue expression pattern. In mice, humans, and other mammals, the production of peripherin is limited to the PNS and subsets of CNS neurons (e.g., the spinal motor neurons, neurons of sensory origin, and small interneurons in the cortex and hippocampus) (20) . Pathologically, peripherin has been found to be associated with pathological aggregates in the motor neurons of patients with amyotrophic lateral sclerosis (21) (22) (23) , and in the murine model of this disease, i.e., the transgenic mice expressing a mutant of the superoxide dismutase-1 (SOD1 G37R ) (24, 25) . In addition to this neurological specificity, peripherin is also produced in islet ␤ cells. Peripherin can be found in islet ␤ cells of mouse embryonic pancreas using histochemistry procedures, but its production in the islets of pancreas of adult mice decreases until becoming undetectable using these same procedures (9) . In our previous study (16) , hybridoma screening was conducted on cryosections of pancreata from adult NOD.RAG-2 Ϫ/Ϫ mice. Hence, when we screened anti-peripherin mAbs, we detected reactivity in the pancreatic nervous system, but not in islets; thus, in accordance with this neuronal staining pattern, instead of anti-neuroendocrine Abs, anti-peripherin mAbs were classified as anti-neuronal Abs.
In the early 90s, peripherin was described as an autoantigen linked to T1D in NOD mice (26, 27) . These studies reported the existence of autoantibodies and T lymphocyte responses against peripherin at the early age of 6 wk and during progressive disease to overt clinical diabetes. The generation of a NOD spleen-derived Ab-secreting hybridoma specific for peripherin indicated an Agdriven selection (28) , and thus an active B lymphocyte response against this autoantigen. However, peripherin was considered a minor T1D autoantigen because several studies indicated that T1D development could be prevented in NOD mice by administering other ␤ cell autoantigens (such as glutamic acid decarboxylase, insulin, and heat shock protein 60) (27, 29 -31) , whereas intrathymic and i.v. injections of peripherin did not have such a protective effect (27) .
Shortly after birth, the pancreas of mice undergoes tissue remodeling to reach adult morphology (32) (33) (34) (35) (36) (37) . As a consequence, massive physiological destruction of pancreatic ␤ cells and autonomous nervous system cells occurs. It has been hypothesized that a defect in the clearance of apoptotic nervous and ␤ cells during this period of time may be crucial in the development of the autoimmune disease in NOD mice (38, 39) . Peripherin is a key factor in neuronal development (20) , and its production, unlike other neurofilaments, is up-regulated after nerve injury and by proinflammatory cytokines, such as IL-6 (40, 41) . Thus, we hypothesize that a defect in the clearance process causes an incipient inflammation that up-regulates the production of peripherin in the pancreatic nervous system and/or ␤ cells and favors the autoreactive response in this proinflammatory context.
The study by Boitard et al. (26) showed that several anti-I-A g7
Abs react against peripherin. This indicates the existence of crossreactivity between the autoantigen and the MHC H-2 I-A g7 molecules, suggesting that it may contribute to the lack of tolerance to islets ␤ cells in NOD mice. Consequently, we analyzed whether our anti-peripherin mAbs reacted against I-A g7 . The results indicated that none of our Abs reacted against I-A g7 molecules (data not shown). In fact, almost all mAbs [20/21] At present, no data has been published on the detection of peripherin autoantibodies in T1D patients. This is surprising, because peripherin was one of the first autoantigens related to diabetes in NOD mice. The lack of published data may be due to the molecular properties of the protein (peripherin, like other intermediate filaments, is extremely insoluble), and to the fact that the first studies indicated that peripherin was not the initial autoantigen in T1D in NOD mice. The findings indicating that most mAbs are directed against the C-terminal sequence of peripherin will allow the use of a soluble peptide for better determining the reactivity of peripherin in T1D patients and in NOD mice in future studies. Therefore, taking into account new data reported in this study, it will be interesting to evaluate the existence of peripherin autoantibodies in both T1D and in patients with diabetic neuropathy.
The presence of an humoral immune response to peripherin in diabetogenesis strongly suggests the existence also of a T lymphocyte-reactive response to this autoantigen, that in the long term could actively participate in the destruction of both PNS and islet ␤ cells.
Lastly, our results suggest a possible relation between the presence of anti-peripherin B lymphocytes and resistance to T1D. The (NOD ϫ NOR)F 1 and 8.3-(NOD ϫ NOR)F 1 mice are considered to be good models of resistance to T1D development, because they suffer severe insulitis but only a few develop T1D (42, 43) . Thus, the fact that the percentage of Ab-secreting hybridomas against peripherin was clearly higher in insulitis-prone but diabetes-resistant (NOD ϫ NOR)F 1 and 8.3-(NOD ϫ NOR)F 1 mice suggests that anti-peripherin B lymphocytes may be involved in the modulation of the autoimmune response in situ. In a recent publication, Razavi et al. (44) demonstrated that the loss of sensory neurons that innervate pancreatic islets in NOD mice prevents insulitis and diabetes in those mice. Interestingly, peripherin knockout mice display a substantial reduction of unmyelinated sensory fibers, thus indicating that peripherin is required for their adequate development (45) . Whether the response to peripherin may contribute to modulating the function of the sensory fibers, that in the long term would help to prevent T1D development in (NOD ϫ NOR)F 1 and 8.3-(NOD ϫ NOR)F 1 mice, is an attractive hypothesis to explore.
We conclude that peripherin is a neuroendocrine autoantigen targeted by a sizable proportion of islet-infiltrating B lymphocytes and that the immunodominant epitope recognized by these B lymphocytes maps at the C-terminal region of this protein. Thus, our study demonstrates that peripherin is a relevant autoantigen in diabetogenesis and poses a new question on why peripherin-specific B lymphocytes are mainly attracted to the islet during the development of T1D.
